Philippe Armand
- Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation 93
- Acute Myeloid Leukemia Research 34
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment 145
- Oncology top 0.1%
- CAR-T cell therapy research 75
- Cancer Immunotherapy and Biomarkers 66
- Immunology top 0.2%
- Immune Cell Function and Interaction 47
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 51
-
- CNS Lymphoma Diagnosis and Treatment 29
- Co-authors
- Joseph H. AntinMargaret A. ShippRobert J. SoifferEdwin P. AlyeaHaesook T. KimCorey CutlerVincent T. HoJohn Koreth
- Journals
- Blood (122 papers)Biology of Blood and Marrow Transplantation (59 papers)Journal of Clinical Oncology (29 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Philippe Armand
324 papers receiving 17.3k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Hematology 5.0k
- Pathology and Forensic Medicine 5.9k
- Oncology 8.8k
- Immunology 6.4k
- Genetics 3.0k
Countries citing papers authored by Philippe Armand
This map shows the geographic impact of Philippe Armand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Armand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Armand more than expected).
Fields of papers citing papers by Philippe Armand
This network shows the impact of papers produced by Philippe Armand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Armand. The network helps show where Philippe Armand may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philippe Armand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 8 | |
| 5 | 2022 | 12 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 22 | |
| 8 | 2020 | 88 | |
| 9 | 2019 | 160 | |
| 10 | 2019 | 1 | |
| 11 | Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trialbreakdown → | 2018 | 455 |
| 12 | 2018 | 111 | |
| 13 | 2018 | 34 | |
| 14 | Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphomabreakdown → | 2017 | 694 |
| 15 | 2017 | 22 | |
| 16 | 2016 | 227 | |
| 17 | 2012 | 104 | |
| 18 | 2011 | 100 | |
| 19 | 2008 | 80 | |
| 20 | 2007 | 318 |
About Philippe Armand
Philippe Armand is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics, having authored 334 papers that have together received 17.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (145 papers), Hematopoietic Stem Cell Transplantation (93 papers), CAR-T cell therapy research (75 papers), Cancer Immunotherapy and Biomarkers (66 papers), Chronic Lymphocytic Leukemia Research (51 papers), Immune Cell Function and Interaction (47 papers), Acute Myeloid Leukemia Research (34 papers) and CNS Lymphoma Diagnosis and Treatment (29 papers). The work is most often cited by research in Hematology (5.0k citations), Pathology and Forensic Medicine (5.9k citations) and Oncology (8.8k citations). Philippe Armand has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Joseph H. Antin, Margaret A. Shipp, Robert J. Soiffer, Edwin P. Alyea, Haesook T. Kim, Corey Cutler, Vincent T. Ho, John Koreth, Scott J. Rodig and Stephen M. Ansell. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Blood Advances and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.